Review reveals potential predictors of long-term distress after cancer diagnosis

January 10, 2018, Wiley

A new review of published studies indicates that distress and neuroticism at or within 3 months of cancer diagnosis may predict emotional distress at least 12 months later. In the Psycho-Oncology analysis, there was no consistent evidence that demographic, clinical, or social factors reliably predict long-term distress.

The investigators noted that studies included in the analysis were varied, with different populations and methods. Therefore, additional studies are needed to test and expand the preliminary findings before any conclusions can be reached.

"While the research suggests that levels of distress and neuroticism around the time of diagnosis are useful markers of vulnerability, further prospective research is now needed in order to understand how these variables might be related and to identify the psychological mechanisms by which distress is maintained," said lead author Dr. Sharon Cook, of the University of Liverpool, in the UK.

Explore further: Cancer distress may lead to missed appointments

More information: Psycho-Oncology (2018). DOI: 10.1002/pon.4601

Related Stories

Cancer distress may lead to missed appointments

September 25, 2017
(HealthDay)—Seriously distressed cancer patients appear to miss more appointments and have more hospital admissions during treatment, a new study finds.

Many young cancer patients do not receive adequate fertility information and support

August 21, 2017
All cancer patients of reproductive age should be provided with fertility information and referrals for fertility preservation. A new Psycho-Oncology analysis of the published literature indicates that many cancer patients ...

Educational session helps alleviate distress in prostate cancer patients and their partners

May 19, 2017
In a recent study, an educational session helped alleviate distress equally in both patients with prostate cancer and their partners.

Diabetes-related distress ups risk for rx nonadherence

October 31, 2016
(HealthDay)—Diabetes-related distress and depression symptom severity are risk factors for medication nonadherence in type 2 diabetes, according to a study published online Oct. 17 in Diabetes Care.

Patients undergoing lung cancer screening experience elevated levels of distress

October 19, 2015
Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but little research regarding the emotional toll of screening has been conducted. ...

Lower socioeconomic status is linked to obesity through distress and emotional eating

May 18, 2017
New research presented at this year's European Congress on Obesity in Porto, Portugal (17-20 May) shows that lower socioeconomic status is associated with higher body-mass index (BMI) through its effects on distress and subsequent ...

Recommended for you

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

Overcoming resistance to a standard chemotherapy drug

July 19, 2018
Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

Study finds melanoma biomarkers predicting checkpoint blocker response

July 18, 2018
Scientists at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood ...

Link found between bitter-taste sensitivity and cancer risk

July 18, 2018
High bitter-taste sensitivity is associated with a significantly increased risk of cancer in older British women, according to researchers who conducted a unique study of 5,500 women whose diet, lifestyle and health has been ...

Scientists discover a mechanism of drug resistance in breast and ovarian cancer

July 18, 2018
There is a highly sophisticated way to treat some breast and ovarian cancers—a class of drugs called PARP inhibitors, designed to exploit the very defects that make tumors with certain mutations especially deadly. Yet this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.